Document Detail


Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss.
MedLine Citation:
PMID:  12707659     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Idiopathic sudden sensorineural hearing loss (ISSNHL) is a vexing problem that continues to pose a diagnostic and therapeutic enigma for the otologist. The aim of the study, adopting the viral theory, was to discover whether patients with ISSNHL would benefit from early treatment with acyclovir and hydrocortisone compared with patients treated by hydrocortisone alone. METHODS: Sixty patients with ISSNHL were treated in a prospective controlled randomized manner. Patients were seen within 7 days of onset and were divided randomly into 2 groups. The study group patients were treated with acyclovir and hydrocortisone, whereas those in the control group were treated with hydrocortisone alone. RESULTS: We compared the 2 groups before and after treatment regarding SRT, mean hearing level at each frequency, speech reception threshold improvement, gender, age, tinnitus, and balance complaints. The overall improvement was 78%. CONCLUSION: We conclude that there probably is no benefit from the addition of acyclovir in the treatment of ISSNHL.
Authors:
Nechama Uri; Ilana Doweck; Raanan Cohen-Kerem; Elhanan Greenberg
Related Documents :
20568909 - Acute mastoiditis in greenland between 1994-2007.
23078909 - Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel d...
22980639 - Effect of femtosecond laser fragmentation of the nucleus with different softening grid ...
19126129 - Prospective cohort comparison of bioactive glass implants and conchal cartilage in reco...
2018439 - Frey's syndrome following parotid surgery.
23016529 - Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in th...
8897259 - Late results after subtrochanteric angulation osteotomy in young patients.
9507709 - Surgery for primary hyperparathyroidism 1962-1996: indications and outcomes.
21838909 - Repeated treatment of recurrent uncomplicated plasmodium falciparum malaria in senegal ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery     Volume:  128     ISSN:  0194-5998     ISO Abbreviation:  Otolaryngol Head Neck Surg     Publication Date:  2003 Apr 
Date Detail:
Created Date:  2003-04-22     Completed Date:  2003-06-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8508176     Medline TA:  Otolaryngol Head Neck Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  544-9     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Carmel Medical Center, Haifa, Israel. druri@netvision.net.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acyclovir / therapeutic use*
Adolescent
Adult
Antiviral Agents / therapeutic use*
Female
Hearing Loss, Sensorineural / drug therapy*
Hearing Loss, Sudden / drug therapy*
Humans
Male
Middle Aged
Prospective Studies
Chemical
Reg. No./Substance:
0/Antiviral Agents; 59277-89-3/Acyclovir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biofeedback rehabilitation for prevention of synkinesis after facial palsy.
Next Document:  Endolymphatic sac-vein decompression for intractable Meniere's disease: long term treatment results.